Isohelix has announced that its state-of-the-art GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics, a leading healthcare technology company and high capacity molecular testing laboratory.

The high-performance, easy-to-use device marks the latest addition to Precision Genetics’ extensive portfolio of validated COVID-19 testing options submitted under the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).

The addition of saliva collection to Precision Genetics’ testing capabilities comes at a time when alternative collection methods for COVID-19 testing are increasingly important. Saliva collection allows a person to expel their saliva into a tube, making it far less invasive than the nasopharyngeal (NP) collection method. In addition, saliva collection offers ease and convenience for more populations and demographics.

The GeneFix Saliva DNA/RNA Collection Devices maximize the yield and quality of the DNA and RNA collected, whilst offering long term stabilization at room temperature. The devices are easy to use and integrate seamlessly into most manual and high-throughput processing kits, with 1 and 2D barcoding, automation-friendly features all specified for leak-proof mailing.

For more information about the GeneFix Saliva DNA/RNA Collection Devices, click here or use the 'Request Information' button provided below.